“IMP-1 Inhibits Renal Cell Carcinoma 786-O Cell Growth by Targeting EphrinB2 Signaling Pathway”. Brazilian Journal of Pharmaceutical Sciences 59 (June 22, 2023): e22102. Accessed April 7, 2025. https://journals.usp.br/bjps/article/view/213468.